Gary K. Lee SEC EDGAR Filings (CIK 0001907345)

SEC EDGAR filings, ownership reports, and insider transactions for Gary K. Lee.

Business address
C/O Lyell Immunopharma, Inc., 201 Haskins Way, South San Francisco, CA, 94080
Top holdings (ownership)
LYEL
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Gary K. Lee has filed 10 SEC EDGAR filings since 04 Feb 2022

Latest Filings

Recent SEC filings for Gary K. Lee including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 12 Nov 2025 10 Nov 2025 001-40502
4 Open 4 document View SEC filing for 4 29 Oct 2025 27 Oct 2025 001-40502
4 Open 4 document View SEC filing for 4 22 Aug 2025 20 Aug 2025 001-40502
4 Open 4 document View SEC filing for 4 13 Aug 2025 11 Aug 2025 001-40502
4 Open 4 document View SEC filing for 4 26 Feb 2025 10 Feb 2025 001-40502
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Feb 2024 09 Feb 2024 001-40502
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 20 Nov 2023 16 Nov 2023 001-40502
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Feb 2023 24 Feb 2023 001-40502
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 14 Feb 2022 11 Feb 2022 001-40502
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 04 Feb 2022 31 Jan 2022 001-40502

About this filer

Gary K. Lee files with the SEC under CIK 0001907345. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages